The Endocrine Society is pleased to offer the 2nd installment of the Obesity Fellows Program, a blended learning experience on best practices in obesity care, exclusively for endocrinology fellows. Chaired by renowned obesity medicine expert Amy Rothberg, MD, DABOM, the Obesity Fellows program is an exclusive, application-based educational activity for current fellows, offering several modes of learning, including:
- An engaging in-person program located in downtown Washington, D.C., at Endocrine Society Headquarters, September 27-28, where fellows get the opportunity to meet with the top experts in the field of obesity care and management.
- 6 on-demand lectures with related pre- and post-test questions, covering foundational topics on obesity clinical practice; and
- Complementary Endocrine News podcast episode
The program accepts up to 50 US-domestic fellows for full participation in the in-person program. Travel, 2-night hotel accommodation, and meal expenses will be covered by the Endocrine Society.
The application period is now closed.
Please contact education@endocrine.org if you have any questions.
2024 Program Agenda
In-Person Workshop
- Keynote Address: Summarizing the Current State of Obesity Management - Michael Weintraub, MD, New York University Medical Center
- Legislative Update on Treat and Reduce Obesity Act: Why We Need Your Help to Advocate to Congress - Rob Goldsmith, Director of Advocacy and Policy, Endocrine Society
- Patient-First Strategies: When & How to Discuss Weight & Factors Affecting Weight Loss and Weight Control - Domenica Rubino, MD, Washington Center for Weight Management & Research
- Body Composition - Ricardo Correa, MD, Cleveland Clinic
- Small Group Discussion: Challenging Cases - Managing Polypharmacy & Comorbidities - Dimpi Desai, MD, Stanford Medicine
- Small Group Discussion: Challenging Cases - Acute & Long-Term Considerations in Weight-Loss Surgery - Jaime Almandoz, MD, UT Southwestern Medical Center
- Lifestyle Interventions to Treat Obesity - David Rometo, MD, UPMC Endocrinology & Diabetes Center
- Side Effects of Pharmacologic Treatment and their Management - Judith Korner, MD, CUIMC/Herbert Irving Pavilion
- Weight Stigma - Lee Kaplan, MD, PhD, Dartmouth Hitchcock Medical Center
- Ask the Experts Session
On-Demand Recordings (to be released on Center of Learning)
- Current Prevalence of Obesity and Definition as a Chronic Disease - Jonathan Purnell, MD, Oregon Health and Science University
- Genetic & Environmental Pathophysiology of Obesity - Michael Weintraub, MD , New York University Medical Center
- Lifestyle Assessment, Intervention & Monitoring in Obesity- Jamy Ard, MD, Weight Management Center at Wake Forest Baptist Health
- Pharmaceutical Options Pt. 1: Past, Current, and Future Options - Amanda Velazquez, MD, DABOM, Cedars-Sinai Center for Weight Management and Metabolic Health
- Pharmaceutical Options Pt. 2: FDA-Approved Pharmacotherapeutic Options for the Treatment of Obesity - Domenica M Rubino, MD, Washington Center for Weight Management & Research
- Updates on Surgical and Procedural Interventions for Obesity - Jaime Almandoz, MD, MBA, MRCPI, FTOS, University of Texas Southwestern Medical Center
Learning Objectives:
Upon successful completion these educational initiatives, participants should be better able to:
- Discuss obesity as a multifactorial, chronic, complex disease, strategies for opening dialogues about obesity, and the effect of weight bias on patients.
- Apply updated knowledge of obesity pathophysiology and external environmental factors (e.g. social determinants of health) when developing treatment plans.
- Evaluate the risks, benefits, indications, and recommendations for behavioral counseling, individualized diets, physical activity, and technologies, for weight management.
- Manage the use of FDA-approved anti-obesity medications by integrating short- and long-term efficacy, safety, and patient-specific factors into treatment plans for sustained weight loss.
- Discuss the risks and benefits of weight loss procedures and surgeries and how to incorporate shared-decision making in patient consultations.
This program was supported by an educational grant from Lilly and Novo Nordisk.
Have questions? Please contact education@endocrine.org for assistance.
